Cargando…
Microbiome-Based Therapeutics in Digestive Diseases: What They Are and How Are They Regulated
Autores principales: | Bishu, Shrinivas, Ginnebaugh, Brian, Chu, Jacqueline, Levy, Benjamin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691787/ https://www.ncbi.nlm.nih.gov/pubmed/38018836 http://dx.doi.org/10.14309/ctg.0000000000000636 |
Ejemplares similares
-
How is the digestive system affected by coronavirus disease?
por: Guo, Jiun-Yu, et al.
Publicado: (2020) -
Editorial to the Special Issue ‘Nutritional Intervention in Digestive Diseases in the Era of Nutraceuticals, Nutrigenomics and Microbiomics’
por: Ashktorab, Hassan, et al.
Publicado: (2023) -
Digesting dietary miRNA therapeutics
por: Yarmarkovich, Mark, et al.
Publicado: (2015) -
Bronchiectasis, the Latest Eosinophilic Airway Disease: What about the Microbiome?
por: Singh, Dave, et al.
Publicado: (2022) -
What Does Influence the Neonatal Microbiome?
por: Pérez-Cano, Francisco J.
Publicado: (2020)